Noble Capital Markets Initiates Coverage On Nanoviricides with Outperform Rating, Announces Price Target of $6
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsInitiationPrice Target
Noble Capital Markets analyst Robert LeBoyer initiates coverage on Nanoviricides (AMEX:NNVC) with a Outperform rating and announces Price Target of $6.
Noble Capital Markets analyst Robert LeBoyer initiates coverage on Nanoviricides (AMEX:NNVC) with a Outperform rating and announces Price Target of $6.